We're attending BIO China 2026 in Guangzhou, China, on 12–14 March 2026.

Bringing together global leaders in biotechnology, life sciences, and biopharmaceutical innovation, BIO China serves as a major platform for scientific exchange, strategic partnerships, and the advancement of cutting‑edge technologies shaping the future of healthcare.

Representing Richmond Pharmacology:

  • Stephen Wilkinson, Business Development Manager

Our Focus at the Exhibition

  • Emerging biotechnology platforms and therapeutic innovations
  • Global clinical development strategies and regulatory pathways
  • Strengthening cross‑border collaboration and partnering opportunities
  • Advances in early‑phase clinical trial design
  • Building sustainable scientific and commercial relationships in the Asia‑Pacific region

Connect With Us

If you are attending BIO China 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

Find out more here: BIOCHINA

Latest news

Richmond supports Beam Therapeutics to make significant step forward in potential one-time gene editing treatment for Alpha-1

March 30, 2026
Beam Therapeutics has announced compelling updated clinical data from its ongoing Phase 1/2 Trial of BEAM-302 as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD).
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event